| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $0.16 (Beat by $0.1) |
| EPS GAAP Actual | $0.16 (Beat by $0.1) |
| Revenue Actual | $0.7587B |
| Revenue Surprise | Beat by $758.7M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.12118 |
| EPS GAAP Estimate | $0.12118 |
| Revenue Estimate | $0.677047233B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.72 | 8.03 | 0.64555 | 0.76919 | 1 |
| Dec 2025 | 0.75 | 7.71 | 0.75 | 0.75 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.1133 | 0.1133 | 0.7587B | 100% | 758.7M |
| FQ1 2025 (Mar 2025) | -0.08 | -0.08 | 0.161599B | 100% | 161.6M |
| FQ4 2024 (Dec 2024) | 0.26 | 0.26 | 0.560207B | 7.21% | 560.21M |
| FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 0.526434B | -28.62% | 526.43M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 0.210542B | 100% | 210.54M |
| FQ2 2019 (Jun 2019) | 0 | 0 | 0.282964B | 100% | 282.96M |
| FQ3 2019 (Sep 2019) | 0 | 0 | 0.449582B | 100% | 449.58M |
| FQ4 2019 (Dec 2019) | 0 | 0 | 0.430233B | 100% | 430.23M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.12118
Consensus Revenue Estimates
0.677047233B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.1297 | -- | 0.11998 | 0.13815 | 1 |
| FQ3 2027 (Sep 2027) | 0.1397 | -- | 0.13223 | 0.14623 | 2 |
| FQ2 2027 (Jun 2027) | 0.13726 | -- | 0.12992 | 0.14368 | 2 |
| FQ1 2027 (Mar 2027) | 0.097163 | -- | 0.091969 | 0.10171 | 2 |
| FQ4 2026 (Oct 2026) | 0.12965 | -- | 0.11796 | 0.14681 | 1 |
| FQ3 2026 (Jul 2026) | 0.12954 | -- | 0.11786 | 0.14668 | 1 |
| FQ2 2026 (Jun 2026) | 0.11347 | 0.15 | 0.10511 | 0.12589 | 4 |
| FQ1 2026 (Mar 2026) | 0.089461 | 189.42 | 0.08287271 | 0.09925539 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.62B | -- | 0.58B | 0.65B | 2 |
| FQ3 2027 (Sep 2027) | 0.61B | -- | 0.59B | 0.63B | 2 |
| FQ2 2027 (Jun 2027) | 0.61B | -- | 0.58B | 0.63B | 2 |
| FQ1 2027 (Mar 2027) | 0.51B | -- | 0.49B | 0.53B | 2 |
| FQ4 2026 (Oct 2026) | 0.52B | -- | 0.48B | 0.57B | 2 |
| FQ3 2026 (Jul 2026) | 0.52B | -- | 0.48B | 0.57B | 2 |
| FQ2 2026 (Jun 2026) | 0.49B | -54.74 | 0.46B | 0.53B | 2 |
| FQ1 2026 (Mar 2026) | 0.43B | 62.39 | 0.41B | 0.47B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
1
EPS # of in-lines
4
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.1133 | 0.1133 | 100% | |
| FQ1 2025 (Mar 2025) | -0.08 | -0.08 | 100% | |
| FQ4 2024 (Dec 2024) | 0.26 | 0.26 | 100% | |
| FQ3 2024 (Sep 2024) | 0.32 | 0.32 | 100% | |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ2 2019 (Jun 2019) | 0 | 0 | NAN% | |
| FQ3 2019 (Sep 2019) | 0 | 0 | NAN% | |
| FQ4 2019 (Dec 2019) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.76B | $758.7M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.16B | $161.6M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.56B | $560.21M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.53B | $526.43M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.21B | $210.54M | 100% |
| FQ2 2019 (Jun 2019) | $0B | $0.28B | $282.96M | 100% |
| FQ3 2019 (Sep 2019) | $0B | $0.45B | $449.58M | 100% |
| FQ4 2019 (Dec 2019) | $0B | $0.43B | $430.23M | 100% |